FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2135683336> ?p ?o ?g. }

• W2135683336 endingPage "568.e4" @default.
• W2135683336 startingPage "560" @default.
• W2135683336 abstract "BackgroundPolymorphisms in the serine protease inhibitor gene serine peptidase inhibitor Kazal type 5 (SPINK5) and the serine protease kallikrein-related peptidase 7 gene (KLK7) appear to confer risk to eczema in some cohorts, but these findings have not been widely replicated. These genes encode proteins thought to be involved in the regulation of posttranslation processing of filaggrin (FLG), the strongest identified genetic risk factor for eczema to date.ObjectivesWe sought to clarify the individual risk of eczema conferred by the SPINK5 polymorphism rs2303067 (Glu420Lys) and a previously described insertion in the 3′ untranslated region of KLK7 and to examine potential epistatic effects between these variants and FLG mutations.MethodsInitially, we examined the effects of these polymorphisms and FLG in 486 unrelated patients from a German family-based study, an additional 287 German patients, and 418 unrelated Irish/English patients with eczema (n for 3 genes studied = 1191 vs 4544 control subjects). We then additionally studied the SPINK5 polymorphism and FLG mutations in 1583 patients with eczema from the Avon Longitudinal Study of Parents and Children cohort (sample size for 2 genes studied = 2774 vs 10,607 control subjects).ResultsNo association was seen with the SPINK5 or KLK7 variants in the case-control analysis; however, a weaker effect was observed for the SPINK5 variant with maternal transmission in the family-based study. No interactions were seen between the polymorphisms in KLK7, SPINK5, and FLG.ConclusionThe SPINK5 420LysSer mutation confers a risk of eczema when maternally inherited but is not a major eczema risk factor. The KLK7 insertion appears to confer no risk of eczema. We found no interaction between the SPINK5 risk allele or the putative KLK7 risk allele and FLG mutations. Polymorphisms in the serine protease inhibitor gene serine peptidase inhibitor Kazal type 5 (SPINK5) and the serine protease kallikrein-related peptidase 7 gene (KLK7) appear to confer risk to eczema in some cohorts, but these findings have not been widely replicated. These genes encode proteins thought to be involved in the regulation of posttranslation processing of filaggrin (FLG), the strongest identified genetic risk factor for eczema to date. We sought to clarify the individual risk of eczema conferred by the SPINK5 polymorphism rs2303067 (Glu420Lys) and a previously described insertion in the 3′ untranslated region of KLK7 and to examine potential epistatic effects between these variants and FLG mutations. Initially, we examined the effects of these polymorphisms and FLG in 486 unrelated patients from a German family-based study, an additional 287 German patients, and 418 unrelated Irish/English patients with eczema (n for 3 genes studied = 1191 vs 4544 control subjects). We then additionally studied the SPINK5 polymorphism and FLG mutations in 1583 patients with eczema from the Avon Longitudinal Study of Parents and Children cohort (sample size for 2 genes studied = 2774 vs 10,607 control subjects). No association was seen with the SPINK5 or KLK7 variants in the case-control analysis; however, a weaker effect was observed for the SPINK5 variant with maternal transmission in the family-based study. No interactions were seen between the polymorphisms in KLK7, SPINK5, and FLG. The SPINK5 420LysSer mutation confers a risk of eczema when maternally inherited but is not a major eczema risk factor. The KLK7 insertion appears to confer no risk of eczema. We found no interaction between the SPINK5 risk allele or the putative KLK7 risk allele and FLG mutations." @default.
• W2135683336 created "2016-06-24" @default.
• W2135683336 creator A5002738902 @default.
• W2135683336 creator A5003242408 @default.
• W2135683336 creator A5008100172 @default.
• W2135683336 creator A5009871877 @default.
• W2135683336 creator A5014484985 @default.
• W2135683336 creator A5014624766 @default.
• W2135683336 creator A5020207419 @default.
• W2135683336 creator A5021058250 @default.
• W2135683336 creator A5021387471 @default.
• W2135683336 creator A5021543281 @default.
• W2135683336 creator A5021862730 @default.
• W2135683336 creator A5022671307 @default.
• W2135683336 creator A5027428528 @default.
• W2135683336 creator A5029600332 @default.
• W2135683336 creator A5030279065 @default.
• W2135683336 creator A5030745516 @default.
• W2135683336 creator A5049416859 @default.
• W2135683336 creator A5052893799 @default.
• W2135683336 creator A5055045080 @default.
• W2135683336 creator A5058073606 @default.
• W2135683336 creator A5063025028 @default.
• W2135683336 creator A5063056062 @default.
• W2135683336 creator A5064731301 @default.
• W2135683336 creator A5071033298 @default.
• W2135683336 creator A5071316058 @default.
• W2135683336 creator A5071626276 @default.
• W2135683336 creator A5074658404 @default.
• W2135683336 creator A5076124471 @default.
• W2135683336 creator A5077872633 @default.
• W2135683336 creator A5080652339 @default.
• W2135683336 date "2008-09-01" @default.
• W2135683336 modified "2023-10-16" @default.
• W2135683336 title "Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk" @default.
• W2135683336 cites W1513902446 @default.
• W2135683336 cites W1530557965 @default.
• W2135683336 cites W1539593569 @default.
• W2135683336 cites W1575310826 @default.
• W2135683336 cites W1578395803 @default.
• W2135683336 cites W1838763289 @default.
• W2135683336 cites W1875061881 @default.
• W2135683336 cites W1965419292 @default.
• W2135683336 cites W1966360257 @default.
• W2135683336 cites W1972857819 @default.
• W2135683336 cites W1974618399 @default.
• W2135683336 cites W1981888845 @default.
• W2135683336 cites W1982906465 @default.
• W2135683336 cites W1983012174 @default.
• W2135683336 cites W1987630808 @default.
• W2135683336 cites W1991309187 @default.
• W2135683336 cites W1999525281 @default.
• W2135683336 cites W1999639094 @default.
• W2135683336 cites W2005039152 @default.
• W2135683336 cites W2005630031 @default.
• W2135683336 cites W2006085701 @default.
• W2135683336 cites W2010796941 @default.
• W2135683336 cites W2011990898 @default.
• W2135683336 cites W2016161201 @default.
• W2135683336 cites W2030046145 @default.
• W2135683336 cites W2034189805 @default.
• W2135683336 cites W2034664214 @default.
• W2135683336 cites W2045363939 @default.
• W2135683336 cites W2045723944 @default.
• W2135683336 cites W2046339224 @default.
• W2135683336 cites W2051489931 @default.
• W2135683336 cites W2053915257 @default.
• W2135683336 cites W2058035002 @default.
• W2135683336 cites W2066224059 @default.
• W2135683336 cites W2068176013 @default.
• W2135683336 cites W2080713361 @default.
• W2135683336 cites W2081368043 @default.
• W2135683336 cites W2086071639 @default.
• W2135683336 cites W2087414659 @default.
• W2135683336 cites W2087985525 @default.
• W2135683336 cites W2091853774 @default.
• W2135683336 cites W2093536554 @default.
• W2135683336 cites W2093948657 @default.
• W2135683336 cites W2112771128 @default.
• W2135683336 cites W2117484254 @default.
• W2135683336 cites W2123344301 @default.
• W2135683336 cites W2126180034 @default.
• W2135683336 cites W2143138262 @default.
• W2135683336 cites W2143488859 @default.
• W2135683336 cites W2147585078 @default.
• W2135683336 cites W2170251081 @default.
• W2135683336 cites W2319931215 @default.
• W2135683336 cites W4245493892 @default.
• W2135683336 doi "https://doi.org/10.1016/j.jaci.2008.05.050" @default.
• W2135683336 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18774391" @default.
• W2135683336 hasPublicationYear "2008" @default.
• W2135683336 type Work @default.
• W2135683336 sameAs 2135683336 @default.
• W2135683336 citedByCount "75" @default.
• W2135683336 countsByYear W21356833362012 @default.
• W2135683336 countsByYear W21356833362013 @default.
• W2135683336 countsByYear W21356833362014 @default.
• W2135683336 countsByYear W21356833362015 @default.

• next